Recognition and Management of Sepsis in Children: Practice Patterns in the Emergency Department

Graham C Thompson1, Charles G Macias2

  • 1Department of Pediatrics, Alberta Children's Hospital/University of Calgary, Calgary, Alberta, Canada.

Insights

Pediatric emergency physicians primarily use clinical signs like tachycardia and altered mental status to diagnose sepsis in children. Future research should focus on identifying clinical biomarkers and standardizing care to improve outcomes.

Area of Science:

  • Pediatric Emergency Medicine
  • Critical Care Medicine
  • Clinical Practice Research

Background:

  • Pediatric sepsis is a significant cause of illness and death in children.
  • Understanding current practices and challenges is crucial for advancing research and education in pediatric sepsis.

Purpose of the Study:

  • To describe how pediatric emergency physicians recognize and manage sepsis in children.
  • To identify key areas for future research and education in pediatric sepsis.

Main Methods:

  • A cross-sectional online survey was distributed to pediatric emergency physicians.
  • The survey was internally developed, externally validated, and used a modified Dillman methodology.
  • Rank scores were calculated to analyze responses.

Main Results:

  • Tachycardia, mental-status changes, and abnormal temperature were top clinical indicators for sepsis diagnosis.
  • Normal saline was the preferred resuscitation fluid; dopamine was the first-line vasoactive medication.
  • Steroid use varied based on presentation complexity, and clinical biomarkers were identified as a research priority.

Conclusions:

  • Pediatric emergency physicians rely heavily on clinical metrics for sepsis recognition, despite some practice variability.
  • Standardizing care and developing clinical biomarkers are priorities for improving pediatric sepsis management.
  • The findings offer a foundation for future research and educational initiatives in pediatric sepsis.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
383
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
701
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
842
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
489
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
786